Combining the age-male-albumin-bilirubin-platelets score and shear wave elastography stratifies carcinogenic risk in hepatitis C patients after viral clearance

Figure 2 Changes over time in the age-male-albumin-bilirubin-platelets score and velocity of shear waves. The age-male-albumin-bilirubin-platelets score is 58.7 ± 8.6 at baseline, 57.8 ± 8.5 at end of treatment, 57.6 ± 8.2 at follow-up 12, and 57.5 ± 8.2 at follow-up 24. No significant fluctuations are seen (P = 0.1862, P = 0.7886, P = 0.8205). A: Velocity of shear waves is 1.55 ± 0.25 m/s at baseline, 1.47 ± 0.25 m/s at end of treatment, 1.43 ± 0.24 m/s at follow-up 12, and 1.43 ± 0.25 m/s at follow-up 24; B: It decreases with time from baseline to follow-up 12, and no significant difference is seen between follow-ups 12 and 24 (P < 0.0001, P = 0.0004, P = 0.7814). EOT: End of treatment.